List of works - Anaïs Pujals

A Study of Hypermethylated Circulating Tumor DNA as a Universal Colorectal Cancer Biomarker

scientific article published on June 2016

BRAF V600E mutations in bile duct adenomas.

scientific article published on 19 May 2014

Bile duct adenoma should not be designated as a reactive process

scientific article

Constitutive autophagy contributes to resistance to TP53-mediated apoptosis in Epstein-Barr virus-positive latency III B-cell lymphoproliferations.

scientific article published on 13 November 2015

DNA degrades during storage in formalin-fixed and paraffin-embedded tissue blocks.

scientific article published on 15 August 2017

Detection of microsatellite instability in a panel of solid tumours with the Idylla MSI Test using extracted DNA

scientific article published on 08 June 2020

Expression of TFH Markers and Detection of RHOA p.G17V and IDH2 p.R172K/S Mutations in Cutaneous Localizations of Angioimmunoblastic T-Cell Lymphomas

scientific article published on 22 September 2017

Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin

scientific article published on 12 January 2017

Multiple Ways to Detect IDH2 Mutations in Angioimmunoblastic T-Cell Lymphoma from Immunohistochemistry to Next-Generation Sequencing

scientific article published on 05 July 2018

PD-L1 expression in perihilar and intrahepatic cholangiocarcinoma.

scientific article

Polymerase proofreading domain mutations: New opportunities for immunotherapy in hypermutated colorectal cancer beyond MMR deficiency

scientific article published on 23 March 2017

Predictive molecular pathology in the time of coronavirus disease (COVID-19) in Europe

scientific article published on 31 July 2020

Pro-apoptotic meiogynin A derivatives that target Bcl-xL and Mcl-1.

scientific article published on 6 September 2014

Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma

scientific article published on 16 June 2016

Targeting STAT6 in PMBL.

scientific article published on September 2014

The IDH2 R172K mutation associated with angioimmunoblastic T-cell lymphoma produces 2HG in T cells and impacts lymphoid development

scientific article published on 12 December 2016

[Lung adenocarcinoma with concomitant EGFR mutation and ALK rearrangement].

scientific article

List of works by Anaïs Pujals

A Study of Hypermethylated Circulating Tumor DNA as a Universal Colorectal Cancer Biomarker

BRAF V600E mutations in bile duct adenomas.

Bile duct adenoma should not be designated as a reactive process

Constitutive autophagy contributes to resistance to TP53-mediated apoptosis in Epstein-Barr virus-positive latency III B-cell lymphoproliferations.

DNA degrades during storage in formalin-fixed and paraffin-embedded tissue blocks.

Detection of microsatellite instability in a panel of solid tumours with the Idylla MSI Test using extracted DNA

Expression of TFH Markers and Detection of RHOA p.G17V and IDH2 p.R172K/S Mutations in Cutaneous Localizations of Angioimmunoblastic T-Cell Lymphomas

Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin

Multiple Ways to Detect IDH2 Mutations in Angioimmunoblastic T-Cell Lymphoma from Immunohistochemistry to Next-Generation Sequencing

PD-L1 expression in perihilar and intrahepatic cholangiocarcinoma.

Polymerase proofreading domain mutations: New opportunities for immunotherapy in hypermutated colorectal cancer beyond MMR deficiency

Predictive molecular pathology in the time of coronavirus disease (COVID-19) in Europe

Pro-apoptotic meiogynin A derivatives that target Bcl-xL and Mcl-1.

Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma

Targeting STAT6 in PMBL.

The IDH2 R172K mutation associated with angioimmunoblastic T-cell lymphoma produces 2HG in T cells and impacts lymphoid development

[Lung adenocarcinoma with concomitant EGFR mutation and ALK rearrangement].